287 related articles for article (PubMed ID: 19895242)
1. Heat-shock protein vaccines as active immunotherapy against human gliomas.
Yang I; Han S; Parsa AT
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1577-82. PubMed ID: 19895242
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein-peptide complex in the treatment of glioblastoma.
See AP; Pradilla G; Yang I; Han S; Parsa AT; Lim M
Expert Rev Vaccines; 2011 Jun; 10(6):721-31. PubMed ID: 21692695
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein vaccines against glioblastoma: from bench to bedside.
Ampie L; Choy W; Lamano JB; Fakurnejad S; Bloch O; Parsa AT
J Neurooncol; 2015 Jul; 123(3):441-8. PubMed ID: 26093618
[TBL] [Abstract][Full Text] [Related]
4. Heat shock proteins in glioblastomas.
Yang I; Fang S; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971
[TBL] [Abstract][Full Text] [Related]
5. Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.
Batich KA; Swartz AM; Sampson JH
Expert Opin Biol Ther; 2015 Jan; 15(1):79-94. PubMed ID: 25327832
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for glioma: promises and challenges.
Han SJ; Zygourakis C; Lim M; Parsa AT
Neurosurg Clin N Am; 2012 Jul; 23(3):357-70. PubMed ID: 22748649
[TBL] [Abstract][Full Text] [Related]
7. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Specific T Cell Activation in Malignant Brain Tumors.
Mohme M; Neidert MC
Front Immunol; 2020; 11():205. PubMed ID: 32117316
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy in human glioblastoma.
Szabo AT; Carpentier AF
Rev Neurol (Paris); 2011 Oct; 167(10):668-72. PubMed ID: 21885075
[TBL] [Abstract][Full Text] [Related]
11. Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.
Tosti G; Cocorocchio E; Pennacchioli E; Ferrucci PF; Testori A; Martinoli C
Expert Opin Biol Ther; 2014 Jul; 14(7):955-67. PubMed ID: 24670226
[TBL] [Abstract][Full Text] [Related]
12. Peptide-based immunotherapeutic approaches to glioma: a review.
Yamanaka R; Itoh K
Expert Opin Biol Ther; 2007 May; 7(5):645-9. PubMed ID: 17477802
[TBL] [Abstract][Full Text] [Related]
13. Tumor antigen-specific T cells for immune monitoring of dendritic cell-treated glioblastoma patients.
Müller I; Altherr D; Eyrich M; Flesch B; Friedmann KS; Ketter R; Oertel J; Schwarz EC; Technau A; Urbschat S; Eichler H
Cytotherapy; 2016 Sep; 18(9):1146-61. PubMed ID: 27424145
[TBL] [Abstract][Full Text] [Related]
14. Vaccine therapies for patients with glioblastoma.
Sayegh ET; Oh T; Fakurnejad S; Bloch O; Parsa AT
J Neurooncol; 2014 Sep; 119(3):531-46. PubMed ID: 25163836
[TBL] [Abstract][Full Text] [Related]
15. Glioma antigen.
Toda M
Adv Exp Med Biol; 2012; 746():77-84. PubMed ID: 22639160
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein--peptide complexes as immunotherapy for human cancer.
Przepiorka D; Srivastava PK
Mol Med Today; 1998 Nov; 4(11):478-84. PubMed ID: 9857367
[TBL] [Abstract][Full Text] [Related]
17. Emerging immunotherapies for glioblastoma.
Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
[TBL] [Abstract][Full Text] [Related]
18. Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report.
Liau LM; Black KL; Martin NA; Sykes SN; Bronstein JM; Jouben-Steele L; Mischel PS; Belldegrun A; Cloughesy TF
Neurosurg Focus; 2000 Dec; 9(6):e8. PubMed ID: 16817691
[TBL] [Abstract][Full Text] [Related]
19. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.
Xu Q; Liu G; Yuan X; Xu M; Wang H; Ji J; Konda B; Black KL; Yu JS
Stem Cells; 2009 Aug; 27(8):1734-40. PubMed ID: 19536809
[TBL] [Abstract][Full Text] [Related]
20. Vaccine strategies for glioblastoma: progress and future directions.
Jackson C; Ruzevick J; Brem H; Lim M
Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
